Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Transaction in Own Shares

30th Dec 2025 07:00

RNS Number : 0415N
CVS Group plc
30 December 2025
 

30 December 2025

 

CVS GROUP plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

Transaction in own shares

 

CVS announces that on 29 December 2025 it purchased the following number of its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg, Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the terms of the share buyback programme announced on 24 October 2025 (the "Share Buyback Programme").

 

Date of purchase:

29/12/2025

Aggregate number of Ordinary Shares purchased:

15,260

Lowest price paid per share (GBp):

1,268.00

Highest price paid per share (GBp):

1,282.00

Volume weighted average price paid per share (GBp):

1,276.03

CVS intends to cancel all of the purchased Ordinary Shares.

 

Following settlement of the above purchases and cancellation of the Ordinary Shares purchased, CVS will have 70,719,089 Ordinary Shares in issue and holds no Ordinary Shares in treasury.

 

The total number of voting rights in CVS is therefore 70,719,089 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, CVS under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

Since the commencement of the Share Buyback Programme, the Company has repurchased 1,021,694 Ordinary Shares in aggregate at a weighted average price of 1,220.60 pence per share.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), as it forms part of Retained EU Law as defined in the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Berenberg as part of the Share Buyback Programme.

 

Individual transactions:

 

Number of

Ordinary Shares purchased

Transaction price (GBp share)

Time of

transaction (UK Time)

Transaction

reference number

Trading Venue

 

198

1268

29/12/2025 08:08:11

1360740812328148

XLON

176

1274

29/12/2025 08:13:02

1360740812328646

XLON

83

1274

29/12/2025 08:55:22

1360740812332264

XLON

497

1278

29/12/2025 09:42:27

1360740812334977

XLON

62

1280

29/12/2025 10:05:29

1360740812335948

XLON

6

1280

29/12/2025 10:05:29

1360740812335949

XLON

345

1280

29/12/2025 10:05:29

1360740812335950

XLON

56

1280

29/12/2025 10:05:29

1360740812335951

XLON

11

1280

29/12/2025 10:05:29

1360740812335952

XLON

307

1280

29/12/2025 10:05:39

1360740812335974

XLON

88

1280

29/12/2025 10:05:39

1360740812335976

XLON

463

1282

29/12/2025 12:56:28

1360740812343152

XLON

195

1282

29/12/2025 12:56:28

1360740812343156

XLON

87

1280

29/12/2025 13:05:00

1360740812343460

XLON

75

1278

29/12/2025 13:29:54

1360740812344473

XLON

69

1278

29/12/2025 14:04:16

1360740812346231

XLON

202

1276

29/12/2025 14:06:30

1360740812346387

XLON

119

1276

29/12/2025 14:06:30

1360740812346389

XLON

87

1274

29/12/2025 14:41:08

1360740812350514

XLON

492

1274

29/12/2025 14:54:02

1360740812352121

XLON

445

1274

29/12/2025 14:54:02

1360740812352126

XLON

120

1268

29/12/2025 14:56:00

1360740812352438

XLON

1

1268

29/12/2025 15:05:09

1360740812353413

XLON

290

1272

29/12/2025 15:11:39

1360740812354279

XLON

186

1272

29/12/2025 15:17:48

1360740812355199

XLON

186

1272

29/12/2025 15:17:48

1360740812355200

XLON

6

1272

29/12/2025 15:17:48

1360740812355201

XLON

6

1272

29/12/2025 15:17:48

1360740812355203

XLON

180

1272

29/12/2025 15:17:48

1360740812355202

XLON

186

1272

29/12/2025 15:17:48

1360740812355204

XLON

186

1272

29/12/2025 15:17:48

1360740812355205

XLON

186

1272

29/12/2025 15:17:48

1360740812355206

XLON

18

1272

29/12/2025 15:17:48

1360740812355207

XLON

100

1272

29/12/2025 15:17:48

1360740812355208

XLON

68

1272

29/12/2025 15:17:48

1360740812355209

XLON

272

1272

29/12/2025 15:17:48

1360740812355210

XLON

186

1272

29/12/2025 15:17:48

1360740812355211

XLON

186

1272

29/12/2025 15:17:48

1360740812355212

XLON

186

1272

29/12/2025 15:32:11

1360740812356793

XLON

186

1272

29/12/2025 15:32:11

1360740812356801

XLON

304

1272

29/12/2025 15:32:11

1360740812356802

XLON

186

1272

29/12/2025 15:32:11

1360740812356803

XLON

304

1272

29/12/2025 15:32:11

1360740812356804

XLON

165

1272

29/12/2025 15:32:11

1360740812356805

XLON

9

1272

29/12/2025 15:32:11

1360740812356806

XLON

12

1272

29/12/2025 15:32:11

1360740812356807

XLON

3

1272

29/12/2025 15:32:11

1360740812356808

XLON

186

1272

29/12/2025 15:32:11

1360740812356809

XLON

159

1272

29/12/2025 15:32:11

1360740812356810

XLON

27

1272

29/12/2025 15:32:12

1360740812356811

XLON

186

1272

29/12/2025 15:32:13

1360740812356819

XLON

68

1272

29/12/2025 15:32:13

1360740812356820

XLON

280

1272

29/12/2025 15:32:13

1360740812356821

XLON

186

1272

29/12/2025 15:51:36

1360740812359028

XLON

534

1276

29/12/2025 15:56:27

1360740812359851

XLON

1426

1276

29/12/2025 15:58:55

1360740812360376

XLON

186

1276

29/12/2025 15:58:55

1360740812360372

XLON

1

1276

29/12/2025 16:07:13

1360740812361680

XLON

49

1280

29/12/2025 16:11:46

1360740812362249

XLON

6

1280

29/12/2025 16:11:46

1360740812362250

XLON

108

1280

29/12/2025 16:11:46

1360740812362251

XLON

120

1280

29/12/2025 16:11:46

1360740812362252

XLON

7

1280

29/12/2025 16:11:46

1360740812362248

XLON

260

1280

29/12/2025 16:11:46

1360740812362253

XLON

190

1280

29/12/2025 16:11:46

1360740812362254

XLON

60

1280

29/12/2025 16:11:46

1360740812362255

XLON

186

1280

29/12/2025 16:11:46

1360740812362256

XLON

186

1280

29/12/2025 16:11:46

1360740812362257

XLON

186

1280

29/12/2025 16:11:46

1360740812362258

XLON

186

1280

29/12/2025 16:11:46

1360740812362259

XLON

186

1280

29/12/2025 16:11:46

1360740812362260

XLON

186

1280

29/12/2025 16:11:46

1360740812362261

XLON

186

1280

29/12/2025 16:11:46

1360740812362262

XLON

186

1280

29/12/2025 16:11:46

1360740812362263

XLON

186

1280

29/12/2025 16:11:46

1360740812362264

XLON

186

1280

29/12/2025 16:11:46

1360740812362265

XLON

186

1280

29/12/2025 16:11:46

1360740812362266

XLON

186

1280

29/12/2025 16:11:46

1360740812362267

XLON

186

1280

29/12/2025 16:11:46

1360740812362268

XLON

169

1280

29/12/2025 16:11:46

1360740812362269

XLON

853

1278

29/12/2025 16:11:46

1360740812362272

XLON

 

 

Contacts

CVS Group plc via Camarco

Richard Fairman, CEO

Robin Alfonso, CFO

Paul Higgs, Chief Veterinary Officer

Charlotte Page, Head of Investor Relations

 

Peel Hunt LLP (Nominated Adviser & Joint Broker) +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark

 

Berenberg (Joint Broker) +44 (0)20 3207 7800

Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing

 

Camarco (Financial PR) [email protected]

Ginny Pulbrook +44 (0)7961 315 138

Letaba Rimell

Tilly Butcher

 

About CVS Group plc (www.cvsukltd.co.uk)

 

CVS Group is an AIM-listed provider of veterinary services with operations in the UK and Australia. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

 

The Group now operates c.470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct").

 

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSPPGUWPUPAGMB

Related Shares:

CVS Group
FTSE 100 Latest
Value9,988.25
Change56.87